tiprankstipranks
Trending News
More News >
Guided Therapeutics (GTHP)
:GTHP
US Market

Guided Therapeutics (GTHP) Income Statement

Compare
24 Followers

Guided Therapeutics Income Statement

Last quarter (Q1 2025), Guided Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Guided Therapeutics's net income was $-463.00K. See Guided Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.00K$ 98.00K$ 13.00K$ 81.00K$ 102.00K
Gross Profit
$ 2.00K$ 36.00K$ -68.00K$ 20.00K$ 61.00K
Operating Expenses
$ 2.11M$ 3.49M$ 3.27M$ 2.38M$ 1.20M
Depreciation and Amortization
$ 95.00K$ 85.00K$ 72.00K$ 1.00K$ 21.00K
EBITDA
$ -1.94M$ -3.13M$ -3.69M$ -919.00K$ 777.00K
Operating Income
$ -2.11M$ -3.46M$ -3.33M$ -2.36M$ -1.05M
Other Income/Expenses
$ -309.00K$ -32.00K$ -1.01M$ 292.00K$ 773.00K
Pretax Income
$ -2.42M$ -3.49M$ -4.34M$ -2.07M$ -279.00K
Net Income
$ -2.42M$ -3.49M$ -4.97M$ -3.73M$ -1.33M
Per Share Metrics
Basic EPS
$ -0.05$ -0.07$ -0.15$ -0.28$ -0.12
Diluted EPS
$ -0.05$ -0.07$ -0.15$ -0.28$ -0.12
Weighted Average Shares Outstanding
57.34M 51.13M 32.51M 13.38M 10.77M
Weighted Average Shares Outstanding (Diluted)
57.34M 51.13M 32.51M 13.38M 10.77M
Currency in USD

Guided Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis